Feb 1 |
IGC Pharma Announces TGR-63 Reduces Agitation in Alzheimer's Mouse Model
|
Jan 23 |
Why IGC Pharma Stock Is Moving Higher
|
Jan 23 |
IGC Pharma Breakthrough: Preclinical Trial Data Shows TGR-63 Reduces Plaque in Alzheimer’s
|
Jan 17 |
IGC Pharma Activates ClinCloud, One of 12 Sites in Ongoing Phase 2b Alzheimer’s Trial
|
Dec 29 |
IGC Pharma files for $100M mixed shelf
|
Dec 19 |
Patent Granted to IGC Pharma for Groundbreaking Drug Formulation to Treat Agitation in Alzheimer’s
|
Dec 13 |
IGC Pharma Announces Participation in Biotech Showcase and BioPartnering @ JPM Alongside the J.P. Morgan 41st Annual Healthcare Conference 2024
|
Dec 6 |
IGC Pharma Announces Collaboration to Integrate AI into Clinical Trials
|
Nov 22 |
AI And THC: IGC Pharma Teams Up With Colombian University For Alzheimer's Treatment Research
|
Nov 21 |
IGC Pharma Announces Master Agreement with Leading South American University to Advance AI Initiatives
|